ARA-290 16mg

ARA-290 (Cibinetide) 16mg is a synthetic 11-amino acid peptide engineered from the tissue-protective region of erythropoietin (EPO). Unlike EPO, ARA-290 does not stimulate red blood cell production and instead selectively targets the Innate Repair Receptor (IRR), a receptor complex involved in regulating inflammation, cellular protection, and tissue repair mechanisms. Research has explored ARA-290's potential role in supporting regenerative processes following tissue injury, reducing inflammatory signaling, and promoting recovery of nerve function. Experimental studies have investigated its effects on neuropathy, nerve fiber regeneration, wound healing, metabolic regulation, cardiovascular health, and immune system modulation. Activation of the IRR pathway has been associated with downstream cellular responses involved in tissue protection and restoration. ARA-290 has become a compound of interest in regenerative medicine and longevity research due to its unique mechanism of action and its ability to engage protective cellular pathways without the hematopoietic effects associated with traditional erythropoietin. Ongoing research continues to examine its applications across a broad range of biological and physiological systems. Key Research Areas Tissue repair and regenerative biology Neuroprotection and nerve regeneration Inflammation and immune response modulation Peripheral neuropathy research Wound healing mechanisms Metabolic and mitochondrial function studies Cardiovascular and healthy aging research